Ionis Pharmaceuticals Inc (IONS)
34.01
+0.07
(+0.21%)
USD |
NASDAQ |
Nov 22, 16:00
33.98
-0.03
(-0.09%)
After-Hours: 20:00
Ionis Pharmaceuticals Free Cash Flow: -374.21M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -374.21M |
| June 30, 2024 | -375.18M |
| March 31, 2024 | -345.48M |
| December 31, 2023 | -335.52M |
| September 30, 2023 | -573.62M |
| June 30, 2023 | -492.84M |
| March 31, 2023 | -405.00M |
| December 31, 2022 | -294.47M |
| September 30, 2022 | 110.43M |
| June 30, 2022 | 81.74M |
| March 31, 2022 | 35.38M |
| December 31, 2021 | 12.90M |
| September 30, 2021 | -95.70M |
| June 30, 2021 | -58.77M |
| March 31, 2021 | -45.24M |
| December 31, 2020 | -5.156M |
| September 30, 2020 | 172.64M |
| June 30, 2020 | 165.29M |
| March 31, 2020 | 188.32M |
| December 31, 2019 | 309.34M |
| September 30, 2019 | 153.84M |
| June 30, 2019 | 153.72M |
| March 31, 2019 | 678.61M |
| December 31, 2018 | 585.25M |
| September 30, 2018 | 485.20M |
| Date | Value |
|---|---|
| June 30, 2018 | 524.88M |
| March 31, 2018 | 27.93M |
| December 31, 2017 | 136.29M |
| September 30, 2017 | 92.28M |
| June 30, 2017 | 105.36M |
| March 31, 2017 | 71.59M |
| December 31, 2016 | -123.63M |
| September 30, 2016 | -133.56M |
| June 30, 2016 | -122.32M |
| March 31, 2016 | -22.98M |
| December 31, 2015 | 9.377M |
| September 30, 2015 | 115.98M |
| June 30, 2015 | 83.11M |
| March 31, 2015 | -15.18M |
| December 31, 2014 | -4.819M |
| September 30, 2014 | -86.83M |
| June 30, 2014 | -23.50M |
| March 31, 2014 | 35.57M |
| December 31, 2013 | 58.13M |
| September 30, 2013 | 108.83M |
| June 30, 2013 | 18.85M |
| March 31, 2013 | -7.621M |
| December 31, 2012 | -3.294M |
| September 30, 2012 | -63.10M |
| June 30, 2012 | -63.79M |
Free Cash Flow Range, Past 5 Years
-573.62M
Minimum
Sep 2023
309.34M
Maximum
Dec 2019
-116.26M
Average
-52.01M
Median
Free Cash Flow Benchmarks
| Biogen Inc | 1.768B |
| Alnylam Pharmaceuticals Inc | 16.06M |
| Biomarin Pharmaceutical Inc | 300.88M |
| Amicus Therapeutics Inc | -31.51M |
| Arbutus Biopharma Corp | -71.92M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -114.99M |
| Cash from Investing (Quarterly) | -340.80M |
| Cash from Financing (Quarterly) | 496.05M |
| Free Cash Flow Per Share (Quarterly) | -0.749 |
| Free Cash Flow to Equity (Quarterly) | -112.78M |
| Free Cash Flow to Firm (Quarterly) | -89.13M |
| Free Cash Flow Yield | -7.54% |